Table 1 Profiles of patients enrolled in this study and clinical responses to the vaccination
patient no. | age | sex | dose of peptide (mg) | adverse events | tumor marker | evaluation of CT imagea) | DTH skin test |
|---|---|---|---|---|---|---|---|
1 | 63 | M | 0.1 | anemia | decreased | MR | -- |
2 | 53 | M | 0.1 | -- | not decreased | PD | -- |
3 | 42 | M | 0.1 | -- | decreased | NC | -- |
4 | 54 | F | 0.1 | -- | Â | Â | Â |
5 | 65 | M | 0.1 | -- | decreased | PD | -- |
6 | 64 | F | 0.1 | general malaise | decreased | PD | + |
7 | 48 | F | 1.0 | -- | decreased | PD | -- |
8 | 62 | F | 1.0 | -- | not decreased | PD | -- |
9 | 64 | M | 1.0 | -- | decreased | PD | -- |
10 | 52 | M | 1.0 | -- | not decreased | PD | + |
11 | 58 | M | 1.0 | -- | not decreased | NC | + |
12 | 58 | F | 10.0 | fever | not decreased | PD | -- |
13 | 62 | F | 10.0 | -- | not decreased | PD | + |
14 | 72 | M | 10.0 | -- | not decreased | PD | + |
15 | 71 | M | 10.0 | -- | Â | Â | Â |
16 | 67 | M | 10.0 | -- | not decreased | PD | -- |
17 | 59 | F | 10.0 | -- | not decreased | NC | + |